Additive pre-diagnostic and diagnostic value of routine blood-based biomarkers in the detection of colorectal cancer in the UK Biobank cohort
G Tanriver, E Kocagoncu - Scientific Reports, 2023 - nature.com
Survival rates from colorectal cancer (CRC) are drastically higher if the disease is detected
and treated earlier. Current screening guidelines involve stool-based tests and …
and treated earlier. Current screening guidelines involve stool-based tests and …
FIT negative clinic as a safety net for low-risk patients with colorectal cancer: impact on endoscopy and radiology utilisation–a retrospective cohort study
Background Faecal immunochemical testing (FIT) is recommended by the National Institute
for Health and Care Excellence to triage symptomatic primary care patients who have …
for Health and Care Excellence to triage symptomatic primary care patients who have …
Establishment and validation of symptomatic patients colorectal screening score for predicting colorectal neoplasia risk
X Wang, X Zhang, J Liu, TY Liu… - Journal of Digestive …, 2023 - Wiley Online Library
Objectives Currently, most colorectal neoplasia (CRN) screening strategies target
asymptomatic individuals. However, studies on patients with non‐specific gastrointestinal …
asymptomatic individuals. However, studies on patients with non‐specific gastrointestinal …
The effect of antiplatelet therapy and oral anticoagulants on the accuracy of faecal immunochemical testing
F Wu, AA Khan, M Klimovskij… - The Annals of The …, 2024 - publishing.rcseng.ac.uk
Introduction Faecal immunochemical testing (FIT) has been adopted to identify patients
requiring further investigations on the colorectal cancer (CRC) referral pathway. We aimed …
requiring further investigations on the colorectal cancer (CRC) referral pathway. We aimed …